May, Richard D.

Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2

Popovic, B., Breed, J., Rees, D. G., Gardener, M. J., Vinall, L. M. K., Kemp, B., Spooner, J., Keen, J., Minter, R., Uddin, F., et al. (2017) · Journal of Molecular Biology

Monoclonal and Polyclonal Antibodies ResearchCytokine Signaling Pathways and Interactions

Cited by 198

Strategies targeting the IL-4/IL-13 axes in disease

May, R. D., & Fung, M. (2015) · Cytokine

Asthma and respiratory diseasesIL-33, ST2, and ILC Pathways

Cited by 166

Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro

Erickson-Miller, C. L., May, R. D., Tomaszewski, J., Osborn, B., Murphy, M. J., Page, J. G., & Parchment, R. E. (1997) · Cancer Chemotherapy and Pharmacology

Cancer therapeutics and mechanismsImmunotoxicology and immune responses

Cited by 111